Published 1986
| Version v1
Book
Inhibition of T cell cytotoxicity by cyclosporine (CSA), adenosine (ADO), and an inhibitor of adenosine deaminase (ADA)
- 1. The University of Texas Health Science Center at San Antonio, San Antonio, TX
Description
This paper tests the effect of cyclosporine (CSA), inhibitor EHNA and adenosine on cytolytic lymphoctyes (CTL). Cytotoxicity assay (5-hr 51Cr-release) was performed using anti-SV40-CTL as effectors in a ratio of 10:1 and 3:1 against the syngeneic target cells bearing SV40 antigens. At a higher E:T ratio of 10:1 there is a slight statistically significant reduction of cytotoxicity for all treatment groups except EHNA + CSA. The most reduction of cytolytic function is seen in treatment group where Ado, EHNA and CSA are combined
Additional details
Publishing Information
- Publisher
- Plenum Press.
- Imprint Place
- New York, NY (USA)
- Imprint Title
- Purine and pyrimidine metabolism in man V
- Journal Page Range
- p. 235-238.
Conference
- Title
- 5. international symposium on human purine and pyrimidine metabolism.
- Dates
- 28 Jul - 1 Aug 1985.
- Place
- San Diego, CA (USA).
INIS
- Country of Publication
- United States
- Country of Input or Organization
- United States
- INIS RN
- 18051120
- Subject category
- S60: APPLIED LIFE SCIENCES;
- Resource subtype / Literary indicator
- Conference
- Descriptors DEI
- ADENOSINE; BIOLOGICAL EFFECTS; BIOLOGICAL FUNCTIONS; CHROMIUM 51; CLONING; ENZYME ACTIVITY; ENZYME INHIBITORS; IMMUNE REACTIONS; IMMUNOSUPPRESSION; IMMUNOTHERAPY; INHIBITION; LYMPHOCYTES; NUCLEOTIDASES; POLYPEPTIDES; RADIOENZYMATIC ASSAY; RADIOIMMUNOASSAY; SPLEEN CELLS; TOXICITY
- Descriptors DEC
- ANIMAL CELLS; BETA DECAY RADIOISOTOPES; BIOLOGICAL MATERIALS; BLOOD; BLOOD CELLS; BODY FLUIDS; CHROMIUM ISOTOPES; CONNECTIVE TISSUE CELLS; DAYS LIVING RADIOISOTOPES; ELECTRON CAPTURE RADIOISOTOPES; ENZYMES; ESTERASES; EVEN-ODD NUCLEI; HYDROLASES; INTERMEDIATE MASS NUCLEI; ISOTOPE APPLICATIONS; ISOTOPES; LEUKOCYTES; MATERIALS; MEDICINE; NUCLEI; NUCLEOSIDES; NUCLEOTIDES; ORGANIC COMPOUNDS; PEPTIDES; PHOSPHATASES; PROTEINS; RADIOISOTOPES; RIBOSIDES; SOMATIC CELLS; THERAPY; TRACER TECHNIQUES